News

Filter

Current filters:

Biotechnology

176 to 185 of 97538 results

AbbVie issues earnings-per-share guidance up 30% for 2015

AbbVie issues earnings-per-share guidance up 30% for 2015

12-01-2015

US drugmaker AbbVie has issued updated guidance about its expected earnings in 2015.

AbbVieAnti-viralsFinancialHumiraPharmaceuticalUSAViekira Pak

US Senators reintroduce bill to allow cheaper drug imports from Canada

12-01-2015

US Senators Amy Klobuchar (Democrat, Minnesota) and John McCain (Republican, Arizona) last week resumed…

CanadaLegalPharmaceuticalPoliticsUSA

China’s FDA approves Chipscreen’s Epidaza

China’s FDA approves Chipscreen’s Epidaza

12-01-2015

Chinese biotech firm Chipscreen Biosciences has received regulatory approval of Epidaza (chidamide),…

BiotechnologychidamideChinaChipscreen BiosciencesEpidazaOncologyRegulation

Esteve could earn $1 billion from pain partnership with Mundipharma and Purdue

Esteve could earn $1 billion from pain partnership with Mundipharma and Purdue

12-01-2015

Swiss drugmaker Mundipharma Laboratories and its independent associated company, Purdue Pharmaceuticals,…

E-52862E-58425Esteve GroupLicensingMundipharmaNeurologicalPharmaceuticalPurdue PharmaResearch

Shire to spend $5.2 billion to buy NPS Pharma

Shire to spend $5.2 billion to buy NPS Pharma

12-01-2015

Recently jilted Ireland-headquartered Shire says it is to acquire NPS Pharmaceuticals, confirming recent…

BiotechnologyEuropeGattexMergers & AcquisitionsNatparaNPS PharmaceuticalsRare diseasesRevestiveShire

KaloBios president and chief executive David Pritchard retires

KaloBios president and chief executive David Pritchard retires

11-01-2015

KaloBios Pharmaceuticals has announced its president and chief executive, David Pritchard, is to retire.

BoardroomBusiness FinanceKaloBios PharmaceuticalsPharmaceuticalPresident and chief executiveUSA

EMA backs record number of drugs for rare diseases in 2014

EMA backs record number of drugs for rare diseases in 2014

11-01-2015

The European Medicines Agency recommended the highest number of orphan designated medicines for marketing…

CyramzaEuropeGazyvaroHoloclarImbruvicaMekinistPharmaceuticalRegulationScenesseTranslarna

Daiichi Sankyo agees to pay $39 million to settle US kickback allegations

Daiichi Sankyo agees to pay $39 million to settle US kickback allegations

11-01-2015

The US subsidiary of Japanese drug major Daiichi Sankyo has agreed to pay the United States and state…

Daiichi SankyoFinancialMarkets & MarketingPharmaceuticalUSA

Sanofi and Regeneron’s alirocumab meets endpoints in cholesterol study

Sanofi and Regeneron’s alirocumab meets endpoints in cholesterol study

09-01-2015

French pharma major Sanofi and Regeneron Pharmaceuticals today announced that two new ODYSSEY trials,…

alirocumabBiotechnologyCardio-vascularRegeneron PharmaceuticalsResearchSanofi

176 to 185 of 97538 results

Back to top